Protein Summary
The membrane-bound isoform 1 is a receptor involved in the development of the cardiovascular system, in angiogenesis, in the formation of certain neuronal circuits and in organogenesis outside the nervous system. It mediates the chemorepulsant activity of semaphorins. It binds to semaphorin 3A, The PLGF-2 isoform of PGF, The VEGF165 isoform of VEGFA and VEGFB. Coexpression with KDR results in increased VEGF165 binding to KDR as well as increased chemotaxis. Regulate VEGF-induced angiogenesis. Binding to VEGFA initiates a signaling pathway needed for motor neuron axon guidance and cell body migration, including for the caudal migration of facial motor neurons from rhombomere 4 to rhombomere 6 during embryonic development (By similarity). The soluble isoform 2 binds VEGF-165 and appears to inhibit its binding to cells. It may also induce apoptosis by sequestering VEGF-165. May bind as well various members of the semaphorin family. Its expression has an averse effect on blood vessel numbe ...more
- ENST00000265371
- ENSP00000265371
- ENSG00000099250
- ENST00000374821
- ENSP00000363954
- ENST00000374822
- ENSP00000363955
- ENST00000374867
- ENSP00000364001
- NRP
- VEGF165R
- NP1
- NRP
- BDCA4
- CD304
- VEGF165R
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
biological process | 1 | ||
protein complex | 1 | ||
transcription factor perturbation | 1 | ||
gene perturbation | 0.99 | ||
protein domain | 0.97 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 874.96 (req: < 5)
Gene RIFs: 325 (req: <= 3)
Antibodies: 810 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 874.96 (req: >= 5)
Gene RIFs: 325 (req: > 3)
Antibodies: 810 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 94
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 6
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0